Teradyne just posted the kind of quarter that makes you re-check the math. Total revenue of $1.33 billion for the quarter ended June 28 more than doubled year over year from $651.8 million, marking a second consecutive record and landing above the high end of guidance. But the headline number matters less than what drove it: AI demand has officially spread from compute silicon to the testers that validate it, and Teradyne sits squarely in that handoff.

The Numbers That Matter
Price LIVE$402.74
Market Cap$63.7B
Forward P/E35.3
Total Revenue (TTM)$4.46B
52-Week Low$106.30
52-Week High$487.91
Analyst Consensus1.6 (Buy)
Analyst Target Mean$449.80
Price refreshes live · All other figures as of August 12, 2026

The AI test-intensity supercycle is why this print matters beyond a single quarter. Every AI accelerator, high-bandwidth memory stack, and networking chip demands more test coverage per dollar of silicon than the generations they replace, and the HBM and next-generation DRAM ramp is forcing memory makers to rebuild final-test capacity that had been quietly shrinking for years. Teradyne's semiconductor test franchise is the tollbooth on that traffic — and the order book says the traffic is accelerating.

The segment detail shows how broad the surge is. Semiconductor Test revenue reached $1.12 billion, up 128 percent year over year, with SoC test contributing $843 million. Compute — AI accelerators, CPUs, and networking silicon — now makes up roughly 70 percent of that SoC total and grew about 600 percent year over year, while integrated system test added $67 million. Product Test rose 26 percent to $107 million and Robotics grew 33 percent to $100 million, with Universal Robots still riding the automation cycle.

Memory was the star inside the star. Memory test revenue hit a record $212 million — a third straight quarter above $200 million — and management now expects the 2026 memory test TAM to come in more than 40 percent larger than 2025, driven by HBM and DRAM strength plus a resurgence in NAND final test. Memory book-to-bill ran above 2, meaning Teradyne booked more than two dollars of orders for every dollar of revenue it shipped. That kind of leading indicator suggests the ramp has legs, not just a quarter of pull-ins.

The mix shift shows up in the aggregate: AI-driven revenue now exceeds 60 percent of total revenue. That scale is flowing to the bottom line. Non-GAAP net income was $389.0 million, or $2.47 per diluted share — up roughly 333 percent from $0.57 a year earlier — while GAAP net income was $374.5 million, or $2.38. Non-GAAP gross margin expanded to 59.8 percent, and non-GAAP operating income of $448 million delivered a 33.7 percent operating margin, proof that this growth is being converted into profit rather than bought.

The balance sheet keeps the bull case honest. Free cash flow came in at $378.4 million for the quarter and $578.8 million for the first half, up 150 percent year over year, against capex of $90.7 million. Teradyne repurchased $69 million of stock, paid $0.13 per share in dividends, and ended June with $355 million in cash and short-term investments against roughly $100 million of total debt — net cash of $255 million on roughly 156.3 million shares outstanding.

Guidance says the momentum carries into the fall. Q3 revenue is expected between $1.20 billion and $1.30 billion, with a $1.25 billion midpoint roughly 21 percent above consensus — the Street was sitting near $1.03 to $1.04 billion. Non-GAAP EPS of $1.85 to $2.15 lands at a $2.00 midpoint, with gross margin guided to 58 to 59 percent and non-GAAP operating margin to 28 to 30 percent. The guide is slightly softer on margin than Q2, but with revenue that far ahead of expectations, investors are unlikely to complain.

CEO Greg Smith framed the quarter as the early innings of something larger, arguing that the wafer fab equipment investment ramp now underway sets the stage for 2027 and beyond. He also flagged that the first half represents roughly 50 to 52 percent of expected annual revenue — an unusually explicit hint that Teradyne's own back-half trajectory is already well mapped. For a company whose history is full of cyclical whiplash, that visibility is itself a signal.

The bottom line: Teradyne is no longer a cyclical test-equipment story waiting for a turn. It is an AI infrastructure compounder with book-to-bill above 2, more than 60 percent of revenue tied to AI, and a memory test TAM growing more than 40 percent this year. If HBM-driven test intensity keeps climbing, the 2027 setup Greg Smith describes could make this quarter look like the warm-up act.

Disclosure: The Signal holds no position in TER. Positions may change. This is not financial advice.